El Monte, CA, United States of America

Lin Wang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fulgent Genetics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lin Wang. Retrieved from https://idiyas.com/inventor/lin-wang-75hkzk2i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lin Wang: Innovator in Pharmaceutical Composition

Introduction

Lin Wang is a notable inventor based in El Monte, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. His work focuses on enhancing drug solubility and efficacy while minimizing side effects.

Latest Patents

Lin Wang holds a patent for a pharmaceutical composition that includes taxane nanoaggregates. This composition comprises sodium bicarbonate and a polymer-drug nanoaggregate, which is designed to improve the solubility and stability of water-insoluble or poorly water-soluble taxanes. The patent outlines a method for treating diseases, including cancer, using this innovative composition.

Career Highlights

Lin Wang is currently associated with Fulgent Genetics, Inc., where he continues to advance his research in pharmaceutical innovations. His work has the potential to significantly impact cancer treatment by improving the delivery and effectiveness of taxane-based therapies.

Collaborations

Lin has collaborated with notable colleagues such as Yun Yen and Yubei Zhang, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.

Conclusion

Lin Wang's contributions to pharmaceutical compositions demonstrate his commitment to improving drug efficacy and patient outcomes. His innovative approaches are paving the way for advancements in cancer treatment and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…